FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry. Described is a group of inventions involving an antibody binding with IL33R (versions), a pharmaceutical composition for binding with IL33R containing the above antibody, use of the named antibody for preparing a pharmaceutical composition, use of named antibody for treating rheumatoid arthritis, non-specific ulcerative colitis or asthma, nucleic acid coding said antibody (versions), an expression vector containing said nucleic acid.
EFFECT: inventions expand the range of antibodies binding with IL33R.
21 cl, 4 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ADVANCED ANTIBODY MOLECULES | 2009 |
|
RU2430111C1 |
| PHARMACEUTICAL FORMULATION CONTAINING ADVANCED ANTIBODY MOLECULES | 2010 |
|
RU2565809C2 |
| ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF | 2012 |
|
RU2658603C2 |
| ANTIBODY AGAINST NR10 AND ITS APPLICATION | 2009 |
|
RU2487136C2 |
| NR10 ANTIBODY AND USING IT | 2008 |
|
RU2531521C2 |
| METHOD FOR OBTAINING BI-SPECIFIC ANTIBODIES, BI-SPECIFIC ANTIBODIES AND THERAPEUTIC APPLICATION OF SUCH ANTIBODIES | 2018 |
|
RU2795240C2 |
| ALPHA5-BETA 1 ANTIBODIES AND USING THEM | 2009 |
|
RU2528736C2 |
| NEW FORM OF IL33, MUTATED FORMS OF IL33, ANTIBODIES, ANALYZES AND METHODS OF USING THEM | 2016 |
|
RU2736299C2 |
| RECOVERED HUMAN ANTIBODY OR ITS ANTIGEN-BINDING FRAGMENT (VERSIONS), METHOD OF TREATING hTNFα-MEDIATED DISEASES WITH MEDIATION THEREOF (VERSIONS), PHARMACEUTICAL COMPOSITION, RECOMBINANT HUMAN ANTIBODY OR ITS ANTIGEN-BINDING FRAGMENT, RECOVERED NUCLEIC ACID (VERSIONS) | 2005 |
|
RU2458704C9 |
| METHODS OF TREATING PSORIASIS | 2008 |
|
RU2475265C2 |
